{
Bio-Rad Laboratories, Inc.

Companies

}
001122334455554433221100
001122334455554433221100

growth opportunities in the tuberculosis diagnostics market through 2033

The global tuberculosis diagnostics market, valued at approximately $2.05 billion in 2023, is projected to grow to $3.6 billion by 2033, driven by advancements in nucleic acid testing and increasing healthcare investments. Key opportunities lie in smear microscopy, active tuberculosis detection, and hospital diagnostics, with significant growth expected in the Asia-Pacific and North America regions. Major players include Beckton, Dickinson and Company, Qiagen, and F. Hoffmann-La Roche, collectively holding a substantial market share.
globenewswire.com
Euro United States Dollar Bio-Techne Corporation Thermo Fisher Scientific Inc. Qiagen N.V. Bio-Rad Laboratories, Inc. PerkinElmer Inc Becton, Dickinson and Company BioMerieux SA Abbott Laboratories USA Show more
Healthcare, Market Report
10:21 06.01.2025

global clinical biomarkers market projected to reach 47 billion by 2031

The global clinical biomarkers market, valued at $25.02 billion in 2023, is projected to reach $47.25 billion by 2031, growing at a CAGR of 8.54%. This growth is driven by rising cancer cases and advancements in diagnostic technologies, despite challenges like high costs and reimbursement issues. Key players include Roche, Abbott, and Johnson & Johnson, with significant developments in biomarker testing for various diseases.
openPR.com
Eurofins Scientific S.E. A PerkinElmer Inc Johnson & Johnson Services Inc. Bio-Rad Laboratories, Inc. Qiagen N.V. Merck KGaA Thermo Fisher Scientific Inc. General Electric Co Siemens Healthineers AG Agilent Technologies, Inc. F. Hoffmann-La Roche Ltd. USA Show more
Healthcare, Market Report
08:45 16.12.2024

global growth trends in the crispr and cas gene market to 2033

The global CRISPR and Cas gene market reached approximately $3.3 billion in 2023, growing at a CAGR of 20.38% since 2018. It is projected to expand to $8.8 billion by 2028 and $24.6 billion by 2033, driven by advancements in cancer therapeutics and gene therapy research. North America leads the market, accounting for 45.3% of the total value in 2023.
GlobeNewswire News Room
United States Dollar Bayer AG Bio-Rad Laboratories, Inc. Pluristem Therapeutics Inc. Genscript Biotech Corporation AstraZeneca PLC Qiagen N.V. Hologic, Inc. Cellectis S.A. Takara Bio Inc. Vertex Pharmaceuticals Inc Thermo Fisher Scientific Inc. Sigma-Aldrich Co. LLC Regeneron Pharmaceuticals Inc Editas Medicine Inc IND GBR ESP CAN AUS ITA IDN JPN BRA DEU FRA RUS KOR CHN USA Show more
Technology & Innovation, Market Report
15:27 13.12.2024

global healthcare market trends forecast significant growth through 2034

In January 2023, a significant acquisition occurred as Verinata Health, Inc. was purchased for $1.9 billion. The market for preterm birth diagnostic kits features key players like Qiagen and Hologic Inc., with products including ffN and PAMG-1 tests, serving hospitals and diagnostic labs across various global regions. The preterm birth prevention market is projected to grow from $1.70 billion in 2024 to over $4.49 billion by 2034, reflecting a robust CAGR of 10.2%.
GlobeNewswire News Room
United States Dollar Illumina, Inc. Bio-Rad Laboratories, Inc. Nanjing Liming Biological Preparations Co., Ltd. Qiagen N.V. Hologic, Inc. USA Bio-Rad Laboratories Invitae Sabyasachi Ghosh Illumina Inc. Natera Inc. Show more
Healthcare, Market Report
15:31 13.11.2024

global immunoassay market growth driven by innovative technologies and rising demand

The global immunoassay market is projected to grow significantly, driven by advancements in enzyme immunoassays, which held over 58.2% market share in 2022. The infectious disease testing segment is expected to expand at a CAGR of 5.6%, fueled by rising global incidences of diseases like HIV and hepatitis. North America leads the market with over 36.2% of revenues, supported by advanced healthcare infrastructure and a high prevalence of chronic diseases.
Spherical Insights
United States Dollar SIEMENS HEALTHINEERS BioMerieux SA Abbott Laboratories Danaher Company Quidel Company Ortho-Clinical Diagnostics Inc. Sysmex Company Bio-Rad Laboratories, Inc. Becton, Dickinson and Company F. Hoffmann-La Roche AG Thermo Fisher Scientific Inc. USA CAN MEX DEU GBR FRA ITA ESP RUS CHN JPN IND KOR AUS BRA ARG ARE SAU QAT ZAF Show more
Healthcare, Market Report
09:51 08.11.2024

bio-rad laboratories receives buy recommendation from ubs amid strong market presence

Bio-Rad Laboratories, Inc. focuses on developing, manufacturing, and marketing products for life science research, clinical diagnostics, and analytical chemistry. Its net sales are primarily derived from clinical diagnostic tests (55.8%) and biological research reagents and instruments (44.1%). The company operates 16 production sites globally, with significant sales in the United States (42%), Europe (30.7%), and Asia (21.1%).
de.marketscreener.com
Euro United States Dollar Bio-Rad Laboratories, Inc. DEU POL SGP USA GBR CHN CHE FRA Show more
TradFi, Market Report
00:55 01.11.2024

bio-rad laboratories receives buy recommendation from ubs amid strong market presence

Bio-Rad Laboratories, Inc. focuses on developing, manufacturing, and marketing products for life science research, clinical diagnostics, and analytical chemistry. Its net sales are primarily derived from clinical diagnostic tests (55.8%) and biological research reagents and instruments (44.1%). The company operates 16 production sites globally, with significant sales in the United States (42%), Europe (30.7%), and Asia (21.1%).
MarketScreener
Euro United States Dollar Bio-Rad Laboratories, Inc. DEU POL SGP USA GBR CHN CHE FRA Show more
TradFi, Market Report
00:55 01.11.2024
Trending
Subcategory
Corporate News Industry Trends Stock Market Updates Retail and Consumer Goods Startups & Entrepreneurship CEO Changes Financial Scams and Security Banking Regulations Global Financial Events Finance Mergers & Acquisitions Market Analysis and Predictions Industry Mergers & Acquisitions Central Bank Actions Hedge Funds & Private Equity Workplace Trends Global Trade Developments Supply Chain Management Government Economic Policies Corporate Social Responsibility AI Innovations
Countries:
USA CHN IND GBR JPN CHE SGP ARE QAT IDN SAU DEU MYS KOR CAN KWT VNM THA ISR NLD
Companies:
Wells Fargo & Company The Goldman Sachs Group, Inc. Tesla, Inc. Barclays PLC Bank of America Corporation NatWest Group plc Apple Inc. JPMorgan Chase & Co. Lloyds Banking Group plc Mastercard Inc Visa Inc. Santander UK plc Morgan Stanley Mercedes-Benz Group AG Amazon.com, Inc. OpenAI ERC USD Tiktok USD DoorDash, Inc. Deliveroo plc Nissan Motor Co., Ltd.
Currencies:
United States Dollar Chinese Yuan British Pound Sterling Euro Swiss Franc Japanese Yen Indonesian Rupiah Indian Rupee Offshore Chinese Yuan United Arab Emirates Dirham Singapore Dollar Qatari Riyal South Korean Won Jordanian Dinar Brazilian Real
People:
Donald Trump Elon Musk Rachel Reeves Warren Buffett Jamie Dimon Charlie Nunn Georges Elhedery Mike Regnier Paul Thwaite Hidenori Tanaka Andrew Bailey Joe Biden Jean Du Boullay Raoul Pal Rosan Roeslani Prabowo Subianto Moeldoko Patrick P. Gelsinger Michael Beckerman Mu Qing

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.